2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123; CAS No. 306-83-2), a colorless light-ether-odor liquid with a boiling point of 27.6°C (at 1 Torr) and an ozone depletion potential of 0.02, is a substitute for a well-known ozone depleting substance trichlorofluoromethane (CFC-11) as a refrigerant, and 500 tons a year was shipped in Japan in 1996 according to the statistics surveyed by the Japan Fluorocarbon Manufacturers Association.
In August, 1997, a workplace was set up to produce a small container (ca. 15 ml in volume) including HCFC-123 as a refrigerant. The manufacturing process consisted of a preparation process, a refrigerant enclosure process in which HCFC-123 liquid is injected into a container, its leakage is checked, and the container is welded, and an inspection process. Use of HCFC-123 increased in mid-September when the refrigerant enclosure process started. This report describes the incident of liver dysfunction among 14 workers repeatedly exposed to HCFC-123 in the processes, and the results of their health surveillance.
Workplace inspection and health surveillance
On 13 October, 1997, two workers came to see an industrial physician, complaining of ill health. The results of liver function tests showed severe liver damage on the next day, and the workers were referred to a hospital. Blood and urine samples were collected from the remaining 12 workers on 14 October. Blood biochemistry examined were aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamyl-transpeptidase (γ-GTP), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), total and direct bilirubin, and detection of hepatitis B antigen and hepatitis A and C antibodies. Hematological indices were also measured. Prevalence of subjective symptoms and their time courses were surveyed through an interview with the industrial physician. Periodical health check-ups continued until the workers' health states were confirmed to be normal. A hygienic survey was also carried out to identify the cause of the observed health effects.
No major chemical, physical or biological hazard except HCFC-123 exposure was identified in the workplace. Exposure to HCFC-123 was estimated to be high in the refrigerant enclosure process not equipped with local exhaust ventilation systems. The workplace was closed on 14 October, and was restarted after the exhaust systems were set up and confirmed to work effectively.
Four out of 14 workers showed signs of severe liver damage with various symptoms (Table) . All of them had worked primarily at the refrigerant enclosure process since mid-September. The first case (case A), who had had fatty liver pointed out in April, 1997, began work in the refrigerant enclosure process on 22 September, and his first symptoms, poor appetite, tightness in the chest and abdominal pain, appeared in early October. On 10 and 11 October, he worked on holidays, and his spouse pointed out his icteroid complexion. On 13 October, he became progressively sicker, and his biochemical tests indicated severe liver damage. All tests were negative for hepatitis viruses. The second case (B) had worked at the refrigerant enclosure process since 18 September, and felt abdominal flatulence and poor appetite by the end of the month. His liver function indices were normal in April, 1997, but were impaired on 13 October with negative results for hepatitis viruses. He also became icteric and vomited by early October. The third case (C) with positive serology for hepatitis A antibody and the fourth case (D) without positive serology also had a similar course since mid-September, complaining of ill health, poor appetite and abdominal pain. Cases C and D had been well when they had engaged in the process in September, but their liver functions were impaired on 14 October. The industrial physician immediately required all of these four workers to take a rest at home until their health conditions ameliorated, and almost all of their liver function tests returned to within the normal range and the symptoms had disappeared by the end of November.
Five workers had a slight increase in AST and ALT with normal bilirubin levels on 14 October (data not shown). One worker had worked in the refrigerant enclosure process in early September, but the other four spent only in a few hours a day at this process. They also had some symptoms such as abdominal pain or headache, but their frequency and degree were low. By the end of November, the health condition of all workers was confirmed to be normal. None of the workers had a HCFC-123 differs depending on the species, probably due to species difference in bioactivation pathways in the liver, which we could guess from the liver toxicity of 1-bromo-1-chloro-2,2,2-trifluoroethane (halothane) 5) , a very similar structure to that of HCFC-123.
In conclusion, severe liver dysfunction was observed among workers who had been exposed to the CFC substitute, HCFC-123. It is necessary to examine the causality between HCFC-123 exposure and liver dysfunction more closely, to clarify the exposure-effect and exposure-response relationships, and to explore the mechanism of HCFC-123 toxicity in humans. history of drug-or alcohol-related liver diseases, and there were no changes in hematological indices in any of the 14 workers.
Discussion
Liver functions were impaired among workers who had been exposed repeatedly to HCFC-123. Incidence of liver dysfunction was high, and its intensity was severe even though the duration of exposure was no more than five weeks. These findings are consistent with the report of Hoet et al. 1) in which exposure to a mixture of HCFC-123 and HCFC-124 resulted in severe liver damage with hepatocellular necrosis. The liver is therefore considered to be a target organ of HCFC-123 exposure in humans.
Toxicological evaluation of CFC replacements by using rats has been done extensively by the Programme for Alternative Fluorocarbon Toxicity Testing 2, 3) , in which inhalation toxicity of HCFC-123 was suggested to be low even in a 2-year exposure experiment at concentrations of 300-5000 ppm. On the other hand, a single exposure to 1000 ppm HCFC-123 for 4 h in guinea pigs caused increase in AST and ALT values with hepatocellular necrosis 4) . These results clearly indicate that susceptibility to
